Skip to main content

Table 1 Clinical characteristics of 831 Taiwanese SLE patients

From: Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese

  Count/available (%) Male (N = 71) Female (N = 760)
SLE case 831/831 (100.00%) 71/831 (8.54%) 760/831 (91.46%)
Age (years), mean ± standard deviation 30.77 ± 11.73 31.72 ± 12.36 30.68 ± 11.68
Oral ulcer 218/831 (26.23%) 14/71 (19.72%) 204/760 (26.84%)
Arthritis 522/831 (62.82%) 39/71 (54.93%) 483/760 (63.55%)
Malar rash 459/831 (55.23%) 39/71 (54.93%) 420/760 (55.26%)
Discoid rash 160/831 (19.25%) 18/71 (25.35%) 142/760 (18.68%)
Photosensitivity 187/831 (22.5%) 14/71 (19.72%) 173/760 (22.76%)
Pleural effusion 158/831 (19.01%) 12/71 (16.9%) 146/760 (19.21%)
Pericardial effusion 100/831 (12.03%) 13/71 (18.31%) 87/760 (11.45%)
Ascites 43/831 (5.17%) 3/71 (4.23%) 40/760 (5.26%)
Total counts for nephritis status 831 (100%) 71 (100%) 760 (100%)
 Nephritis negative 370/831 (44.52%) 25/71 (35.21%) 345/760 (45.39%)
 Nephritis positive 461/831 (55.48%) 46/71 (64.79%) 415/760 (54.61%)
Neuropsychiatric manifestations 133/831 (16%) 10/71 (14.08%) 123/760 (16.18%)
Leukopenia (WBC count < 3500/μl) 466/831 (56.08%) 41/71 (57.75%) 425/760 (55.92%)
Anemia (hemoglobin < 9 g/dl) 252/831 (30.32%) 11/71 (15.49%) 241/760 (31.71%)
Thrombocytopenia (platelet count < 105/μl) 215/831 (25.87%) 23/71 (32.39%) 192/760 (25.26%)
Anti-dsDNA 618/813 (76.01%) 54/70 (77.14%) 564/743 (75.91%)
Complement depressed 632/818 (77.26%) 54/69 (78.26%) 578/749 (77.17%)
Anti-RNP 292/677 (43.13%) 24/62 (38.71%) 268/615 (43.58%)
Anti-Sm 256/678 (37.76%) 28/63 (44.44%) 228/615 (37.07%)
Anti-SSA 362/560 (64.64%) 30/48 (62.5%) 332/512 (64.84%)
Anti-SSB 149/560 (26.61%) 8/48 (16.67%) 141/512 (27.54%)
Anticardiolipin IgG 184/655 (28.09%) 12/50 (24%) 172/605 (28.43%)
Anticardiolipin IgM 55/600 (9.17%) 4/48 (8.33%) 51/552 (9.24%)
  1. Data presented as count/available (%)
  2. SLE systemic lupus erythematosus, WBC white blood cell